 |
We offer a variety of different clinical trials for patients with Parkinson’s disease and Movement Disorders. Some of these trials are led by Dr. Smith and her study team, while others are sponsored by pharmaceutical companies to test new therapies. The specific clinical trials offered at our center change frequently, so please contact us if you are interested in general in participating in research. Join our research volunteer database at https://www.conqueringdiseases.org/ |
Speech, Linguistic and Acoustic Markers in Parkinson's Disease (SLAM-PD)
Aims to identify speech and language markers that provide information on cognitive function and predict cognitive decline in Parkinson's disease. The Investigators administer speech tasks and cognitive assessments to participants with Parkinson's disease and healthy controls. The Investigators explore associations between genetic factors and speech and cognitive status in Parkinson's disease. ClinicalTrials.gov Identifier: NCT04273672
Current status: Active; Enrolling Patients
Open to: Patients with Parkinson's disease
PI: Kara Smith, MD
Conquering Diseases - Trial
An 18-month Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Oral UCB0599 in Study Participants with Early-stage Parkinson's Disease
Assess the safety and tolerability of UCB0599 and demonstrate the superiority of UCB0599 over placebo regarding clinical symptoms of disease progression over 12 and 18 months in participants diagnosed with early-stage Parkinson's Disease. ClinicalTrials.gov Identifier: NCT04658186
Current status: Active; Not Enrolling Patients
Open to: Patients with early-stage Parkinson's disease
PI: Kara Smith, MD
Conquering Diseases - Trial
Heart rate variability as a biomarker in Parkinson’s disease
description of the study ClinicalTrials.gov Identifier:
Current status: Active; Not Enrolling Patients
Open to: Patients with Parkinson's disease
PI: Kara Smith, MD
Conquering Diseases - Trial
For all studies contact Tatiana Thompson at tatiana.thompson@umassmed.edu or 508-856-8989